<div id="readability-page-1"><div><p>Health care stocks followed the main indexes in a post-holiday decline, before bouncing back to close slightly higher, among a lack of market-moving news and data points.</p><p>    Arcadia Biosciences declined after the termination of a merger agreement with Roosevelt Resources that was announced just over a year ago. The company will resume its evaluation of strategic alternatives. </p><p>    Moderna, a major stock in the sector, was a top loser in the S&amp;P 500, although no particular piece of news seemed to be the culprit. </p><p>   Write to Paulo Trevisani at paulo.trevisani@wsj.com </p><p>    (END) Dow Jones Newswires</p><p>12-26-25 1751ET</p></div></div>

MRNA

<p>醫療保健股票在假期後最初下跌，但隨後恢復並小幅收高。Arcadia Biosciences 在與 Roosevelt Resources 結束合併後股價下跌，而 Moderna 在沒有具體消息導致下跌的情況下成為標準普爾 500 指數中的最大輸家</p>

醫療保健股票在尾盤交易中反彈——醫療保健綜述